Recommendations for inclusion in the Authorisation List

Recommendations for inclusion in the Authorisation List

Applications imbriquées

 

The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV (the "Authorisation List") to the European Commission, taking into account comments received from interested parties and the opinion of the Member State Committee. The European Commission finally decides, which substances will be included in Annex XIV and what the associated entries will be.

The below table includes all Candidate List substances that have been included in ECHA's draft or final recommendations for inclusion in Annex XIV. The "Status"- column indicates whether the substances have been included in a draft recommendation, recommended for inclusion or are already included in Annex XIV. Further details and documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.

Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds along with the other substances on the Candidate List. They may be included in future recommendations. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
 

Recommendations for inclusion in the Authorisation List

Last updated 24 mai 2022. Database contains 111 unique substances/entries.
Filter the list
Intrinsic property
Date of final recommendation
Date of inclusion in the Authorisation List

The List does not contain any Substances.
 
231-589-4
7646-79-9
Carcinogenic (Article 57a)
Toxic for reproduction (Article 57c)
3rd recommendation
Recommended for inclusion in Annex XIV
20-déc.-2011
Details
208-169-4
513-79-1
Carcinogenic (Article 57a)
Toxic for reproduction (Article 57c)
3rd recommendation
Recommended for inclusion in Annex XIV
20-déc.-2011
Details
204-450-0
121-14-2
Carcinogenic (Article 57a)
2nd recommendation
Included in Annex XIV (Authorisation List)
17-déc.-2010
Details
215-116-9
1303-28-2
Carcinogenic (Article 57a)
2nd recommendation
Included in Annex XIV (Authorisation List)
17-déc.-2010
Details
215-481-4
1327-53-3
Carcinogenic (Article 57a)
2nd recommendation
Included in Annex XIV (Authorisation List)
17-déc.-2010
Details
201-553-2
84-69-5
Toxic for reproduction (Article 57c)
Endocrine disrupting properties (Article 57(f) - human health)
2nd recommendation (2010), amendment recommendation (2019)
Included in Annex XIV (Authorisation List)
17-déc.-2010
Details
231-846-0
7758-97-6
Carcinogenic (Article 57a)
Toxic for reproduction (Article 57c)
2nd recommendation
Included in Annex XIV (Authorisation List)
17-déc.-2010
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.
235-759-9
12656-85-8
Carcinogenic (Article 57a)
Toxic for reproduction (Article 57c)
2nd recommendation
Included in Annex XIV (Authorisation List)
17-déc.-2010
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.
215-693-7
1344-37-2
Carcinogenic (Article 57a)
Toxic for reproduction (Article 57c)
2nd recommendation
Included in Annex XIV (Authorisation List)
17-déc.-2010
Details
204-118-5
115-96-8
Toxic for reproduction (Article 57c)
2nd recommendation
Included in Annex XIV (Authorisation List)
17-déc.-2010
Details
287-476-5
85535-84-8
PBT (Article 57d)
vPvB (Article 57e)
1st recommendation
Recommended for inclusion in Annex XIV
01-juin-2009
Details
201-557-4
84-74-2
Toxic for reproduction (Article 57c)
Endocrine disrupting properties (Article 57(f) - human health)
1st recommendation (2009), amendment recommendation (2019)
Included in Annex XIV (Authorisation List)
01-juin-2009
Details
201-622-7
85-68-7
Toxic for reproduction (Article 57c)
Endocrine disrupting properties (Article 57(f) - human health)
1st recommendation (2009), amendment recommendation (2019)
Included in Annex XIV (Authorisation List)
01-juin-2009
Details
204-211-0
117-81-7
Toxic for reproduction (Article 57c)
Endocrine disrupting properties (Article 57(f) - environment)
Endocrine disrupting properties (Article 57(f) - human health)
1st recommendation (2009), amendment recommendation (2019)
Included in Annex XIV (Authorisation List)
01-juin-2009
Details
and all major diastereoisomers identified
show/hide
1,2,5,6,9,10-hexabromocyclodecane EC No.: 221-695-9 | CAS No.: 3194-55-6
Hexabromocyclododecane EC No.: 247-148-4 | CAS No.: 25637-99-4
alpha-hexabromocyclododecane EC No.: 603-801-9 | CAS No.: 134237-50-6
beta-hexabromocyclododecane EC No.: 603-802-4 | CAS No.: 134237-51-7
gamma-hexabromocyclododecane EC No.: 603-804-5 | CAS No.: 134237-52-8
-
-
PBT (Article 57d)
1st recommendation
Included in Annex XIV (Authorisation List)
01-juin-2009
Details
202-974-4
101-77-9
Carcinogenic (Article 57a)
1st recommendation
Included in Annex XIV (Authorisation List)
01-juin-2009
Details
201-329-4
81-15-2
vPvB (Article 57e)
1st recommendation
Included in Annex XIV (Authorisation List)
01-juin-2009
Details

Export search results to:

EU Privacy Disclaimer

Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.